Secondary genomic alterations in Ewing sarcoma.

被引：0
|
作者：
Uche, An
Chow, Warren Allen
Millis, Sherri Z.
机构：
[1] Harbor UCLA, Torrance, CA USA
[2] City Hope Canc Ctr, Duarte, CA USA
[3] Fdn Med Inc, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11024
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prospective clinical genomic profiling of ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biological and therapeutic relevance
    Elkrief, Arielle
    Ogura, Koichi
    Bowman, Anita S.
    Koche, Richard P.
    Benayed, Ryma
    Mauguen, Audrey
    Mattar, Marissa S.
    Khodos, Inna
    de Stanchina, Elisa
    Meyers, Paul A.
    Healey, John H.
    Tap, William D.
    Shukla, Neerav
    Hameed, Meera
    Zehir, Ahmet
    Sawyers, Charles
    Bose, Rohit
    Slotkin, Emily
    Ladanyi, Marc
    CLINICAL CANCER RESEARCH, 2022, 28 (18)
  • [32] Progress towards development of an exosome-based biomarker assay in Ewing sarcoma.
    Samuel, Glenson
    Crow, Jennifer
    Atay, Safinur
    Godwin, Andrew K.
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 28 - 29
  • [33] A multicenter evaluation of treatment patterns and outcomes for Adamantinoma-like Ewing sarcoma.
    Dorand, Rodney Dixon
    Wang, Daniel Ying
    Keedy, Vicki Leigh
    Davis, Elizabeth J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] EXTRASKELETAL, INTRADURAL, NON-METASTATIC EWING'S SARCOMA. CASE REPORT
    Ottoffy, Gabor
    Komaromy, Hedvig
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2020, 73 (7-8): : 286 - 288
  • [35] Analysis of genomic alterations in Ewing sarcoma (German cohort) reveals cooperating mutations and novel therapy targets
    Richter, G. H. S.
    Agelopoulos, K.
    Schmidt, E.
    von Heyking, K.
    Moser, B.
    Klein, H. U.
    Kontny, U.
    Dugas, M.
    Poos, K.
    Korsching, E.
    Buch, T.
    Koehler, G.
    Roessig, C.
    Baumhoer, D.
    Juergens, H.
    Burdach, S.
    Berdel, W. E.
    Mueller-Tidow, C.
    Dirksen, U.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 134 - 134
  • [36] RNA helicase DDX3 is a novel therapeutic target for Ewing sarcoma.
    Loeb, David Mark
    Wilky, Breelyn A.
    Kim, Catherine
    McCarty, Gregory
    DeVine, Lauren R.
    Cole, Robert N.
    Raman, Venu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Use of PET/CT for staging of Ewing's sarcoma. Report of one case
    Barahona Z, Daniela
    Adlerstein L, Isabel
    Faure R, Maria Ignacia
    REVISTA MEDICA DE CHILE, 2020, 148 (10) : 1504 - 1507
  • [38] I VALUE OF LOCAL TREATMENT MODALITIES IN PATIENTS WITH LOCALIZED EWING SARCOMA. REPORT FROM THE EWING 2008 TRIAL
    Heesen, Philip
    Ranft, Andreas
    Bhadri, Vivek
    Brichard, Benedicte
    Collaud, Stephane
    Cyprova, Sona
    Eich, Hans
    Ek, Torben
    Gelderblom, Hans
    Hardes, Jendrik
    Haveman, Lianne
    Hartmann, Wolfgang
    Hauser, Peter
    Jurgens, Heribert
    Kanerva, Jukka
    Kuehne, Thomas
    Raciborska, Anna
    Rascon, Jelena
    Streitbuerger, Arne
    Timmermann, Beate
    Uhlenbruch, Yasmine
    Dirksen, Uta
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [39] Letter to the editor: "Secondary cancers after Ewing sarcoma and Ewing sarcoma as second malignant neoplasm"
    Aparicio, J
    Segura, A
    Montalar, J
    Verdeguer, A
    Castel, V
    Sanchez-Heras, AB
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 30 (04): : 259 - 260
  • [40] Secondary Malignancies following Ewing Sarcoma Treatment
    Kaiser, Isabelle
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 139 - 139
12345